Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023;13(3):421-426.
doi: 10.3233/JPD-225071.

Visualization of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Results

Affiliations

Visualization of the Movement Disorder Society Unified Parkinson's Disease Rating Scale Results

Jaimie Hixson et al. J Parkinsons Dis. 2023.

Abstract

We sought to design a data visualization platform to represent the Movement Disorder Society- Unified Parkinson's Disease Rating Scale (MDS-UPDRS) item scores in an easy-to-use display without modification of the raw data or summary scores. Score items for Parts I, II, and IV were arranged as separate inline blocks, while Part III item blocks were arranged in an anatomical fashion. A color scale was created to represent symptom severity and changes observed from one exam to another. We have found the visualization helpful for quickly defining the most troublesome symptoms and their anatomical location enabling communication of the results and interpretations.

Keywords: Unified Parkinson’s Disease Rating Scale.

PubMed Disclaimer

Conflict of interest statement

CvH, JH, and JEQ have a financial interest in the development of the visualization tool. Other authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Arranging and color coding a data visualization of the MDS-UPDRS Part III score. A) The classification and organization of assessed MDS-UPDRS Part III items are shown. MDS-UPDRS items are first classified by body location and then rearranged into anatomical organizational groups. Numbers displayed in cells are item numbers from the MDS-UPDRS. B) Arrangement of Parts I, II, and IV with numbers displayed corresponding to items from the MDS-UPDRS are shown. C) This is the legend for UPDRS scoring results. The numeric score reported by the assessed patient or examiner were color coded for ease of interpretation. D) Shown is when the cursor hovers over the cell of interest, a comment box appears with a description of the test item the cell represents. In this case, item 3.18: constancy of rest tremor.
Fig. 2
Fig. 2
A data visualization of the MDS-UPDRS disease severity and impact of medication. A) Patient UPDRS results: Exam 1 (Off) vs. Exam 2 (On) are shown. B) Change in patient score calculated by subtracting Exam 2 scores from Exam 1 scores are shown. Changes in points defined by color code are shown. Cool colors (greens and blues) indicate items with a point improvement. Items that had no change from Exam 1 to Exam 2 are depicted in a gray scale. “A” is for consistently asymptomatic and “S” for symptomatic but unchanged from Exam 1 to Exam 2. Point worsening in a symptom is depicted by yellows and reds.

References

    1. Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 23, 2129–2170. - PubMed
    1. Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ (2002) Systematic evaluation of rating scales for impairment and disability in Parkinson’s disease. Mov Disord 17, 867–876. - PubMed
    1. Tosin MHS, Goetz CG, Luo S, Choi D, Stebbins GT (2020) Item response theory analysis of the MDS-UPDRS motor examination: Tremor vs. nontremor items. Mov Disord 35, 1587–1595. - PubMed
    1. Creed JC (1986) Leonardo da Vinci, Vitruvian Man. JAMA 256, 1541–1541. - PubMed
    1. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord 25, 2649–2653. - PubMed

Publication types